Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
A newly developed risk prediction model that incorporates both genetic and environmental factors could lead to the earlier identification of patients at high risk for colorectal cancer.
This editorial discusses the potential role of ovarian suppression as part of a patient-tailored approach to the treatment of young women's breast cancer.
The COVID-19 pandemic has resulted in delays and disruptions in health care. Has it similarly affected the treatment of patients with metastatic cancer?
About the Publication:
The Journal of the National Cancer Institute (print ISSN: 0027-8874, online ISSN: 1460-2105) publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment.